ChartRow logo
TEM
$75.61-2.81%
as of close, Nov 4, 2026
☾ AH $75.61 -2.81%
PeersVEEVBTSGTWSTTXGSPYQQQ
Share this page

TEM — Tempus AI Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in TEM be worth today? →
TEM returns: By year · By month · By week · Trailing

Key stats#

Price data

Price
$75.61
YTD price return
+28.04%
YTD total return
+28.04%
Market cap
13.8B
Enterprise value
14.6B
Shares outstanding
182.4M
52W low
$40.77
52W high
$89.09
From 52W high
-15.13%
From 52W low
+85.45%
52W range
72%$40.77–$89.09

Volume

Rel volume
0.86×
30D volume
6.9M
30D $ vol
513.3M

Insider trading

Insider net 1W
none
Insider net 1M
−$17.6M
Insider net 3M
−$90.5M
Insider net 1Y
−$167.2M

Form 4 transactions by trade date, as filed; latest on file 2026-10-27.

Fundamentals

Sales (ttm)
1.5B
Sales/share
$8.27
EPS (ttm)
-$1.05
FCF (ttm)
-150.6M
FCF/share
-$0.83
Book value/share
$2.74
Net margin
-12.54%
ROE
-37.83%
ROA
-7.72%
Debt / equity
2.70×
Current ratio
2.61

Growth (CAGR, ttm) · 10Y

Sales
+36.59%+46.15%n/an/a
Shares
+2.53%+42.30%n/an/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share
+33.22%-0.48%n/an/a
Book value/share
-3.89%n/an/an/a
Dividend/share
-47.11%n/an/an/a
Price
-10.52%+30.18%n/an/a
Total return
-10.52%+30.18%n/an/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
-72.0×
Fwd P/E
-1713.9×
P/S (ttm)
9.1×
P/B (mrq)
27.6×
EV/Sales (ttm)
9.7×
FCF yield (ttm)
-1.09%
Buyback yield (realized, 1y)
-2.53%
Shareholder yield (realized, 1y)
-2.53%
Buyback yield (cash, ttm)
0.02%
Shareholder yield (cash, ttm)
0.02%

Performance · price returntotal return · as of 2026-11-04#

1D
-2.81%
5D
-1.31%
1M
-1.33%
3M
+60.70%
YTD
+28.04%
1Y
-10.51%
5Y
—
1D
-2.81%
5D
-1.31%
1M
-1.33%
3M
+60.70%
YTD
+28.04%
1Y
-10.51%
5Y
—

Fundamentals#

Revenue

YoY +23.1%
$1.5B TTM$411.5M Q3 '26
FY22FY23FY24FY25TTM
Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

YoY n/m
−$278.9M TTM−$56.9M Q3 '26
FY22FY23FY24FY25TTM
Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

YoY n/m
−$1.05 TTM−$0.08 Q3 '26
FY22FY23FY24FY25TTM
Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

YoY n/m
−$150.6M TTM−$5.5M Q3 '26
FY22FY23FY24FY25TTM

TTM: operating cash flow −$108.4M, capex −$42.3M

Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $9.2M, capex −$14.8M

Shares (diluted)

YoY +3.6%
180.2M TTM181.3M Q3 '26
FY22FY23FY24FY25TTM
Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

— FY25
FY22FY23FY24FY25

No quarters filed for this figure.

Full TEM financials →

About Tempus AI#

Tempus AI Inc Class A Common Stock is the equity of Tempus AI, a healthcare technology company focused on applying artificial intelligence and machine learning to precision medicine. The company develops AI-enabled solutions that help physicians use clinical and molecular data to support more personalized care, while also providing tools and services that assist life-sciences customers with research, diagnostics, and therapeutic development. Its current business is organized around genomics, data, and artificial intelligence applications, with products spanning next-generation sequencing, molecular profiling, clinical decision support, and software-based diagnostic tools. Tempus AI serves healthcare providers, researchers, and pharmaceutical and biotechnology companies across oncology and other clinical areas, including cardiology, neuropsychiatry, infectious disease, and radiology. The stock represents ownership in a company positioned at the intersection of healthcare, data analytics, and diagnostic innovation.

Chicago, IL·3,800 employees·Health Information Services·tempus.com·As of Oct 30, 2026

Recent filings#

All filings and insider trades →

ETFs holding TEM#

21 of the 193 ETFs ChartRow carries live hold TEM. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
ARKKARK Innovation ETF4.9%
IBBiShares Biotechnology ETF0.5%
VBKVanguard Small-Cap Growth ETF0.2%
IWPiShares Russell Mid-Cap Growth ETF0.2%
VHTVanguard Health Care ETF0.1%
VBVanguard Small-Cap ETF0.1%
VXFVanguard Extended Market ETF0.1%
IWRiShares Russell Midcap ETF0.0%
TickerName1M1D
LLYEli Lilly and Company+24.07%+0.61%
JNJJohnson & Johnson+7.92%+3.81%
ABBVAbbVie Inc.+12.18%+3.09%
MRKMerck & Co. Inc.+4.20%+3.93%
UNHUnitedHealth Group Incorporated Common Stock (DE)+10.08%+1.22%
NVSNovartis AG+17.01%+3.59%
TMOThermo Fisher Scientific Inc.+7.84%+1.12%
AMGNAmgen Inc.+18.69%+3.71%